| Objective: To observe the oral yangyintongnao particle treatment of stroke patients recovering from brain (Qi and Yin Deficiency, blood stasis permits) the clinical therapeutic effect.Methods: The patients were observed from Changchun University of Chinese Medicine First Affiliated Hospital of 60 cases of outpatients. The phaseâ…¡clinical trial of the number of cases: 15 cases of high-dose group, low-dose group 15 cases, 15 cases of positive drug control group, placebo-controlled group of 15 cases. Yangyintongnao brain particles, 5.5g / times; Xiaoshuan pass particles, 10g / times; placebo, 5.5g / times; each group were taken orally, three times a day, are the basis of therapeutic drugs: Adalat Aspirin 1 tablet (100mg) / day, oral bedtime. Continuous oral administration of medication in each group were 28 days to end the treatment.Results: Through clinical trials, treatment of drug yangyintongnao patients with hemiplegic cerebral particles in raising, tongue skew, speech or language Jian Shibuya, partial body numbness, etc. better than the control group of drug particles Xiaoshuan Pass (P <0.05).Conclusion: yangyintongnao brain particles can significantly improve stroke recovery (Qi and Yin Deficiency, blood stasis permits) in patients with clinical symptoms of stroke, its clinical efficacy good, no obvious toxic side effects and adverse reactions. |
PDF Full Text Request